| Product Name |
Dabigatran Inhouse Impurity 3 / Desethyl Dabigatran Etexilate
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Metabolites, Heterocycles, Pharmaceutical Standards, Bases and Related Reagents, Nucleotides, Fine Chemicals, Aromatics |
| CAS No |
212321-78-3 |
| Catalog Number |
GS.01.DAB.33 |
| Chemical Name/Synonyms |
N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine; O-Desethyl Dabigatran Etexilate; Dabigatran Etexilate O-Desethyl Impurity; Etexilate Acid Impurity; Desethyl Pradaxa; Dabigatran JPBA Impurity 5; 3-{[(2-{[(4-{N'-Hexyloxycarbonyl carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-pyridin-2-yl-amino)propanoic Acid; 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic Acid; Dabigatran etexilate Acid (USP); |
| Molecular Weight |
599.68 |
| Molecular Formula |
C32H37N7O5 |
| Purity |
NLT 95 % |
| Applications |
It reduces the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation. |
| Inventory Status |
customized
|
